Akagündüz Baran, Akin Telli Tugba, Sezgin Goksu Sema, Yildirim Hasan Cagri, Ozer Muhammet, Göktaş Aydin Sabin, Ozyurt Neslihan, Karacin Cengiz, Paydas Semra, Dogan Mutlu
Medical Oncology, Erzincan Binali Yıldırım Üniversitesi Mengücek Gazi Hastanesi, Erzincan, TUR.
Medical Oncology, Marmara University Medical School, Istanbul, TUR.
Cureus. 2021 Feb 13;13(2):e13324. doi: 10.7759/cureus.13324.
Objectives Head and neck soft tissue sarcomas (HNSTSs) are a heterogeneous group of rare tumors. Surgical resection with negative margins remains the standard primary treatment for patients with HNSTS. The role of chemotherapy (CT) and radiotherapy (RT) remains controversial. In this multicenter study, we aimed to demonstrate the real-world assessing prognostic factors and the effect of adjuvant treatment modalities in adult patients with HNSTS treated with upfront surgery. Methods We included a total of 47 patients who underwent curative-intent resection of a primary HNSTS between 2000 and 2019. Results The median follow-up was 29 months. The median age of patients was 51 years, and 66% of patients were male. The median relapse-free survival (RFS) of the study population was 31 months (range: 1.0-61.1 months), and the median overall survival (OS) was 115 months (range: 60.8-169.2 months). The univariable analysis revealed that treatment modalities showed a significant impact on RFS (p = 0.021); however, no difference was found in its impact on OS (p = 0.137). R0 resection did not showed impact on RFS (p = 0.130), but a significant association was found with OS (p = 0.004). In multivariable analysis, T stage of the tumor (hazard ratio [HR]: 3.834; 95% CI: 1.631-9.008; p = 0.002) and treatment with surgery and sequential RT and CT (HR: 0.115; 95% CI: 0.035-0.371; p < 0.001) were independent factors associated with RFS. R0 resection was independently associated with OS (HR: 4.902; 95% CI: 1.301-18.465; p = 0.019). Conclusion Our study revealed that R0 resection improved OS, and T3-4 stage of tumor was a negative independent factor for RFS in surgically resected HNSTS patients. The use of sequential CT and RT after resection was associated with a better RFS, which emphasizes the importance of multidisciplinary evaluation of the treatment of HNSTS. Randomized prospective studies are needed.
目的 头颈部软组织肉瘤(HNSTSs)是一组异质性罕见肿瘤。手术切缘阴性的手术切除仍是HNSTS患者的标准初始治疗方法。化疗(CT)和放疗(RT)的作用仍存在争议。在这项多中心研究中,我们旨在展示对接受 upfront 手术治疗的成年 HNSTS 患者评估预后因素及辅助治疗方式效果的真实情况。方法 我们纳入了2000年至2019年间共47例行原发性 HNSTS 根治性切除的患者。结果 中位随访时间为29个月。患者的中位年龄为51岁,66%为男性。研究人群的中位无复发生存期(RFS)为31个月(范围:1.0 - 61.1个月),中位总生存期(OS)为115个月(范围:60.8 - 169.2个月)。单变量分析显示,治疗方式对RFS有显著影响(p = 0.021);然而,其对OS的影响未发现差异(p = 0.137)。R0切除对RFS无影响(p = 0.130),但与OS有显著关联(p = 0.004)。多变量分析中,肿瘤的T分期(风险比[HR]:3.834;95%置信区间:1.631 - 9.008;p = 0.002)以及手术联合序贯RT和CT治疗(HR:0.115;95%置信区间:0.035 - 0.371;p < 0.001)是与RFS相关的独立因素。R0切除与OS独立相关(HR:4.902;95%置信区间:1.301 - 18.465;p = 0.019)。结论 我们的研究表明,R0切除可改善OS,肿瘤T3 - 4期是手术切除的HNSTS患者RFS的负面独立因素。切除后序贯CT和RT的使用与更好的RFS相关,这强调了HNSTS治疗多学科评估的重要性。需要进行随机前瞻性研究。